Lupin (LUPIN) — Financial Results

Lupin reported FY2025 net profit of ₹33,063 crores, up 70.8% YoY, driven by 12.9% revenue growth to ₹221,921 crores. EBITDA rose 39.4% to ₹54,792 crores, with margin expanding to 24.7% from 20.0%. The board recommended a 600% dividend. Q4 saw PAT of ₹7,824 crores, up 112.5% YoY, though down 8.9% QoQ. Operating working capital was ₹68,212 crores, and net debt stood at ₹-3,096 crores.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 14 May 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 14 May 2025

SBIN State Bank of India Corporate Action TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Corporate Action TATAPOWER Tata Power Company Limited Financial Results TATAPOWER Tata Power Company Limited Corporate Action TATAPOWER Tata Power Company Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.